Mania kliinilised uuringud osariigis California
5 uuringut haiguse Mania jaoks otsivad osalejaid osariigis California.
Linnad osariigis California
Ametlik uuringutekst (inglise keeles)
An Assessment of Efficacy, Safety, and Pharmacokinetics of NBI-1117568 in Adults With Bipolar I Disorder With Current Mania
- Neurocrine Clinical Site, Cerritos
- Neurocrine Clinical Site, Garden Grove
- Neurocrine Clinical Site, San Diego
VärbamineFaas 2
Vanused 18–65 · Kõik sood · Uuendatud 29. sept 2026 · NCT07288320A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)
- Proscience Research Group, Culver City
- Clinical Innovations, Inc. dba CITrials, Riverside
- Collaborative Neuroscience Research, LLC, Torrance
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 24. sept 2026 · NCT06951711A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder
- Advanced Research Center Inc., Anaheim
- CITrials, Bellflower
- Local Institution - 0014, Cerritos
- ja veel 3
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 22. sept 2026 · NCT06951698A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
- Advanced Research Center Inc., Anaheim
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Local Institution - 0044, Cerritos
- ja veel 10
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 14. sept 2026 · NCT06929273A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
- Clinical Innovations, Inc. dba CITrials, Bellflower
- Inland Psychiatric Medical Group., Chino
- Proscience Research Group, Culver City
- ja veel 4
VärbamineFaas 3
Vanused 18–65 · Kõik sood · Uuendatud 23. juuni 2026 · NCT07140913Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.